Loading...
News
    Shows

      REPLACED by INGESTION - Generic drug maker skipped steps required for FDA approval

      |A Ranbaxy whistleblower uncovered disturbing problems with the data required by the FDA to prove the effectiveness of drugs. Dinesh Thakur found that the company received approval to sell drugs that were based on no data or data that was fraudulent. John Miller reports.

      Related Videos